USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/10271
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHarea, Dumitru
dc.date.accessioned2020-06-09T05:05:15Z
dc.date.available2020-06-09T05:05:15Z
dc.date.issued2009
dc.identifier.citationHAREA, Dumitru. Particularităţile tabloului clinic la pacienţii cu guşă difuză toxică depistată primar la debutul bolii. In: Arta Medica. 2009, nr. 3(36), pp. 20-24. ISSN 1810-1852.en_US
dc.identifier.issn1810-1852
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/10271
dc.descriptionCatedra Endocrinologie, USMF “Nicolae Testemiţanu”en_US
dc.description.abstractIntroducere: În cazul hipertiroidiei subclinice (HS), spre deosebire de hipertiroidia manifestă (HM), opiniile sunt divergente referitor la manifestările clinice. Scopul lucrării a fost studierea particularităţilor clinice şi hormonale la pacienţii cu guşă difuză toxică (GDT) depistată primar în dependenţă de gradul de exprimare a hipertiroidiei. Materiale şi metode: Studiul a cuprins 130 pacienţi (20 bărbaţi şi 110 femei) cu GDT, cu vârsta între 18 şi 54 ani (vârsta medie 38,23±10,52 ani) şi durata medie a maladiei de 6,88±3,26 luni, precum şi 20 persoane sănătoase. Pacienţii au fost divizaţi în 4 grupe: cu hipertiroidie (tireotoxicoză) subclinică (15,38% pacienţi), uşoară (16,15%), medie (29,23%) şi gravă (39,23%). Pacienţii au fost examinaţi clinic complex, funcţia glandei tiroide fiind apreciată prin dozarea hormonilor tiroidieni. Rezultate: La pacienţii cu HM au fost prezente manifestări clinice caracteristice GDT, cu predominarea celor cardiovasculare şi neuropsihice. În HS endogenă, similar HM, cele mai frecvente manifestări clinice sunt fatigabilitatea, palpitaţiile, nervozitatea şi scăderea ponderală. Nivelul hormonilor tiroidieni la toţi pacienţii, inclusiv cu HS, a fost semnificativ mai mare comparativ cu persoanele sănătoase. Concluzii: Manifestările clinice în HS endogenă sunt mai puţin pronunţate şi mai puţin specifice comparativ cu HM. Tahicardia sinusală este cel mai frecvent şi constant semn clinic caracteristic pentru hipertiroidie şi reflectă gradul de severitate al tireotoxicozei. În HM nivelul crescut al hormonilor tiroidieni reflectă severitatea tireotoxicozei.en_US
dc.description.abstractUnlike overt hyperthyroidism (OH), in subclinical hyperthyroidism (SH) opinions are divergent on clinical manifestations. Objective of paper was to study the clinical and hormonal particularity in patients with primary detected Grave’s disease depending on the degree of expression of hyperthyroidism. Subjects and methods: The study included 130 patients (20 men and 110 women) with Grave’s disease, aged 18 and 54 years (mean age 38,23±10,52 years) and average disease duration of 6,88±3,26 months and 20 healthy people. Patients were divided into 4 groups: with subclinical (15,38% patients), mild (16,15%), medium (29,23%) and severe (39,23%) hyperthyroidism (thyrotoxicosis). Patients were examined clinically, thyroid function was assessed by determining serum levels of thyroid hormones. Results: In patients with OH were present characteristic clinical manifestations for Grave’s disease, the cardiovascular and neuropsychological signs and symptoms were prevail. The most common clinical manifestations of endogenous subclinical hyperthyroidism, like to over hyperthyroidism, are fatigue, palpitation, nervousness and lose weight. The serum levels of thyroid hormones in all patients, including those with SH, was significantly higher compared with healthy individuals. Conclusions: In patients with subclinical hyperthyroidism, the symptoms and signs are much less severe and not as specific as they are in OH. Sinus tachycardia is the most frequent and consistent clinical sign caracteristic for hyperthyroidism and reflects the degree of severity of thyrotoxicosis. The increased levels of thyroid hormone in over hyperthyroidism reflect the severity of thyrotoxicosis.
dc.language.isoroen_US
dc.publisherAsociaţia chirurgilor “Nicolae Anestiadi” din Republica Moldovaen_US
dc.subjectsubclinical hyperthyroidismen_US
dc.subjectGrave’s diseaseen_US
dc.subjectclinical featuresen_US
dc.subjectthyrotoxicosisen_US
dc.subject.meshGraves Disease--diagnosisen_US
dc.subject.meshGraves Disease--physiopathologyen_US
dc.subject.meshGraves Disease--diagnostic imagingen_US
dc.subject.meshHyperthyroidism--diagnosisen_US
dc.subject.meshHyperthyroidism--complicationsen_US
dc.subject.meshThyrotoxicosis--diagnosisen_US
dc.subject.meshThyrotoxicosis--physiopathologyen_US
dc.titleParticularităţile tabloului clinic la pacienţii cu guşă difuză toxică depistată primar la debutul boliien_US
dc.title.alternativeThe particularity of clinical features in patients with diffuse toxic goiter detected at the onset of diseaseen_US
dc.typeArticleen_US
Appears in Collections:Arta Medica Vol. 36 No 3, 2009



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback